1. Companies
  2. Nectar Lifesciences Share Price : NECLIFE

Nectar Lifesciences Share Price : NECLIFE

Nectar Lifesciences Limited was founded in 1995. It is a key player in the Indian pharmaceutical industry, specializing in the manufacturing of pharmaceutical products. Nectar Lifesciences share price reflects market trends in the pharmaceutical sector and the demand for healthcare products and medications.

Summary

  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Phone 91 17 2504 7915
  • Website https://www.neclife.com

Major Holders Breakdown

  • 47.86% % of Shares Held by All Insider
  • 0.06% % of Shares Held by Institutions
  • 0.12% % of Float Held by Institutions
  • 2 Number of Institutions Holding Shares

Historical Chart

Try It Now
Adv banner 1
Stock Health and Score
53 Total Score
  • Fair Value : 52.10
  • Margin of Safety : 30%
  • Value Score :
    68
  • Growth Score :
    70
  • Quality Score :
    60
  • Technical Score :
    34
Support and Resistance
Short Term
3rd Resistance Point
42.37
2nd Resistance Point
41.35
1st Resistance Point
40.84
Last Settled Price
40.08
1st Support Level
39.30
2nd Support Level
38.28
3rd Support Level
37.26
Trade Orders Information
Order No. Entry Price Take Profit Invest % Exp. Payoff % Target Exp. Days
Currently buying is not recommended in this company.
Ad banner 2
Similar Stocks Expert Picks
Similar Stocks not found
Pivot Points
Time Period Pivot Distance Trend
Daily 38.85 -9.67 Bearish
Weekly 39.86 -10.68 Bearish
Monthly 39.28 -10.10 Bearish
Average True Range (ATR)
Time Period ATR Moved Remaining
Daily 1.02 0.99 0.03
Weekly 4.17 1.73 2.44
Monthly 8.05 4.18 3.87
Technical Snapshot (Daily)
Indicator Value Signal Remarks
STOCH 1 Over Sold
RSI 47 Neutral
BBAND 29.18 Over Sold
ATR 1.02 Volatility Down
MACD 0.26 Above Zero
SAR 38.15 Under Price
SMA20 39.22 Under Price
SMA50 37.67 Under Price
SMA100 39.24 Under Price
SMA200 35.95 Under Price
Inside Transactions
Insider Trading Relationship Date Transaction Cost #Shares Value ($)
Latest News
Sebi slaps Rs 10 lakh penalty on Axis Securities for violating stock brokers rules
Feb 22, 2025 12:07 PM
FIIs pull over Rs 1.12 lakh crore from Indian equities in 2025 so far amid 'Sell India, Buy China' trends
Feb 22, 2025 10:36 AM
Zomato, Jio Financial to bloat Nifty valuation, making it even pricier
Feb 22, 2025 10:12 AM
FII exodus: 5 sectors hit hardest by foreign fury in early February
Feb 22, 2025 09:15 AM
India Inc: Key takeaways from Q3 earnings season for investors
Feb 22, 2025 08:58 AM
Concurrent Gainers: Vedanta among 8 stocks on a 5-day winning streak
Feb 22, 2025 08:57 AM
Tesla India entry a limited threat to Mahindra as de-rating priced in after 17% drop in share price: CLSA
Feb 22, 2025 08:39 AM
Rethinking metrics for long-term investment success
Feb 22, 2025 07:49 AM
The rise of margin trading facility in India: A regulated product for smarter investing
Feb 22, 2025 07:07 AM
Who’s losing big? Zomato among top 10 stocks that FIIs trimmed in Q3
Feb 22, 2025 06:44 AM
Try It Now